What does progression mean for Pancreatic Cancer and what happens next

Pancreatic CancerMay 17, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Progression in Pancreatic Cancer

I'm glad you're asking about this important concept. Let me explain what progression means and what typically happens next in pancreatic cancer care.

What Does Progression Mean?

Progression means that your cancer is growing or spreading despite treatment. More specifically, doctors define it as:

  • Tumor growth: The existing cancer is getting larger
  • New tumors appearing: Cancer is spreading to new areas of your body (metastasis)
  • Biomarker changes: Blood markers like CA 19-9 are rising, suggesting increased cancer activity

According to the medical guidelines I have access to, progression is tracked through:

  • Imaging scans (CT, MRI, PET scans) that show tumor size changes
  • Blood tests measuring CA 19-9 levels
  • Clinical symptoms that suggest the cancer is advancing

Why Progression Matters in Pancreatic Cancer

Pancreatic cancer is particularly aggressive, and as noted in the CancerPatientLab webinars on pancreatic cancer, progression can happen relatively quickly. The disease often develops multiple resistance mutations simultaneously—meaning different areas of the cancer may develop different ways to resist treatment.

What Happens Next After Progression

When progression occurs, your oncology team typically takes these steps:

STEP 1: Reassess Your Situation

Your doctors will:

  • Review imaging and blood work to understand how the cancer has progressed
  • Discuss your overall health and how you're tolerating treatment
  • Consider your goals and quality of life

STEP 2: Explore Treatment Options

According to Dr. [removed] O'Reilly's guidance on novel pancreatic cancer therapies, the field is rapidly evolving. Your options may include:

If you haven't had genetic testing yet:

  • Molecular profiling (genetic testing of your tumor) becomes even more critical at progression
  • Testing can identify specific mutations that may respond to targeted therapies
  • This includes testing for KRAS mutations, BRCA1/BRCA2, PALB2, and other DNA repair defects

Potential treatment approaches:

  • Different chemotherapy combinations (if you haven't tried them)
  • Targeted therapies based on your tumor's genetic profile:
    • KRAS inhibitors (if you have a KRAS mutation—present in ~90% of pancreatic cancers)
    • PARP inhibitors (if you have DNA repair defects like BRCA mutations)
    • Other targeted drugs based on specific mutations
  • Immunotherapy approaches, particularly if you have specific biomarkers like mismatch repair deficiency
  • Clinical trials with newer drug combinations or novel approaches

STEP 3: Consider Clinical Trials

This is particularly important for pancreatic cancer. According to Let's Win Pancreatic Cancer resources, clinical trials may offer the best chance for long-term survival because:

  • New drug combinations are being tested
  • You may access treatments not yet widely available
  • Research shows pancreatic cancer patients in clinical trials often have better outcomes than those receiving standard treatment outside trials

Important Questions to Ask Your Oncology Team

When progression is diagnosed, bring these questions to your next appointment:

  1. "What type of progression is this—local growth, spread to new areas, or both?"
  2. "Have we done complete molecular profiling (genetic testing) of my tumor? If not, can we do it now?"
  3. "Based on my tumor's genetic profile, what targeted therapy options might be appropriate for me?"
  4. "Are there clinical trials I'm eligible for, and what would participation involve?"
  5. "What are the goals of the next treatment—to shrink the tumor, slow growth, or manage symptoms?"
  6. "How will we measure whether the new treatment is working?"

The Evolving Treatment Landscape

An important point from Dr. O'Reilly's 2024 guidance: "What was best six months or a year ago may be old news. The pace of change is increasing exponentially." This means:

  • New FDA approvals are happening regularly
  • Combination therapies (chemotherapy + targeted therapy + immunotherapy) are showing promise
  • Getting a second opinion from a major academic cancer center is valuable—they stay current with the latest options

Managing Quality of Life

Regardless of what happens next, remember that palliative care (supportive care focused on quality of life) is important at every stage. This includes:

  • Pain management
  • Nutritional support
  • Managing side effects
  • Addressing emotional and psychological needs

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: